Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ATGE Stock Forecast 2026-2027
$112.39
Current Price
$4.08B
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ATGE Price Targets
+55.7%
To High Target of $175.00
+53.5%
To Median Target of $172.50
+51.3%
To Low Target of $170.00
ATGE Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
-7.8%
1 Year Change
+8.6%
Year-to-Date Change
-28.1%
From 52W High of $156.26
+29.2%
From 52W Low of $86.97
📊 TOP ANALYST CALLS
Did ATGE Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Adtalem is one of their latest high-conviction picks.
Latest ATGE Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, ATGE has a bullish consensus with a median price target of $172.50 (ranging from $170.00 to $175.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $112.39, the median forecast implies a 53.5% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Alexander Paris at Barrington Research, suggesting a 51.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ATGE Analyst Ratings
2
Buy
0
Hold
0
Sell
ATGE Price Target Range
Low
$170.00
Average
$172.50
High
$175.00
Current: $112.39
Latest ATGE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ATGE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 2, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Jan 29, 2026 | Barrington Research | Alexander Paris | Outperform | Maintains | $170.00 |
| Oct 31, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Oct 15, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Sep 23, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Aug 8, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jul 30, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| May 12, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| May 9, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Apr 23, 2025 | Jefferies | Buy | Initiates | $N/A | |
| Apr 15, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Feb 3, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Jan 31, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jan 17, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Oct 30, 2024 | BMO Capital | Outperform | Maintains | $N/A | |
| Oct 30, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Aug 29, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Aug 8, 2024 | BMO Capital | Outperform | Maintains | $N/A | |
| Aug 8, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Jul 24, 2024 | Barrington Research | Outperform | Maintains | $N/A |
Adtalem Global Education Inc. (ATGE) Competitors
The following stocks are similar to Adtalem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Adtalem Global Education Inc. (ATGE) Financial Data
Adtalem Global Education Inc. has a market capitalization of $4.08B with a P/E ratio of 14.5x. The company generates $1.89B in trailing twelve-month revenue with a 13.4% profit margin.
Revenue growth is +12.4% quarter-over-quarter, while maintaining an operating margin of +22.9% and return on equity of +18.0%.
Valuation Metrics
Market Cap
$4.08B
Enterprise Value
$4.11B
P/E Ratio
14.5x
PEG Ratio
10.6x
Price/Sales
1.9x
Growth & Margins
Revenue Growth (YoY)
+12.4%
Gross Margin
+59.2%
Operating Margin
+22.9%
Net Margin
+13.4%
EPS Growth
+0.7%
Financial Health
Cash/Price Ratio
+1.5%
Current Ratio
0.7x
Debt/Equity
52.9x
ROE
+18.0%
ROA
+8.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Adtalem Global Education Inc. (ATGE) Business Model
About Adtalem Global Education Inc.
What They Do
Provides healthcare education across multiple regions.
Business Model
Covista Inc. generates revenue through its diverse educational offerings, including degree and non-degree programs across various fields such as nursing, health professions, and veterinary medicine. The company operates multiple universities and schools, allowing it to cater to a wide range of students and professionals seeking advanced education and certifications.
Additional Information
The company operates under several well-known institutions including Chamberlain University and Walden University, which enhances its brand recognition in the education sector. Having rebranded from Adtalem Global Education Inc. in February 2026, Covista Inc. continues to expand its services in the United States and internationally, positioning itself as a significant player in the healthcare education market.
Company Information
Sector
Consumer Defensive
Industry
Education & Training Services
Employees
4,703
CEO
Mr. Stephen W. Beard J.D.
Country
United States
IPO Year
2017
Website
www.covista.comAdtalem Global Education Inc. (ATGE) Latest News & Analysis
Latest News
Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day
3 months ago
Quick Summary
Covista (NYSE: ATGE) will host its Investor Day today at 9 a.m. ET. The company has grown its student base to over 97,000 and will now trade under the ticker CVSA.
Why It Matters
Covista's growth in student enrollment and its rebranding with a new ticker symbol reflect its strong market position and potential for future revenue growth, influencing investor sentiment positively.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zacks Premium research service offers Zacks Style Scores, aiding value, growth, and momentum investors in identifying strong stocks.
Why It Matters
Zacks Style Scores help investors identify strong stocks across different strategies, enhancing decision-making and potentially improving portfolio performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Ross University School of Medicine Welcomes New Dean
3 months ago
Quick Summary
Covista (NYSE: ATGE) appointed Dr. Cheryl Holmes as the new dean of Ross University School of Medicine, effective March 16. She brings extensive experience in clinical practice and academic leadership.
Why It Matters
Dr. Holmes' appointment as dean could enhance RUSM's reputation and educational quality, potentially attracting more students and improving future financial performance for Covista.
Source: Business Wire
Market Sentiment:
Neutral
Why This $14 Million Bet on Adtalem Global Stock Could Signal a Healthcare Education Pivot
4 months ago
Quick Summary
First Sabrepoint Capital Management initiated a 135,000-share stake in Adtalem Global Education in Q4, increasing the position's value by $13.97 million.
Why It Matters
The initiation of a significant stake in Adtalem Global Education by Sabrepoint Capital indicates growing institutional interest, potentially boosting the stock's value and investor confidence.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Adtalem (ATGE) is currently oversold, suggesting potential for a trend reversal as Wall Street analysts are raising earnings estimates.
Why It Matters
Adtalem's oversold status and analysts' raised earnings estimates suggest a potential rebound, signaling a buying opportunity and possible price recovery for investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Investors in the Schools sector may consider Adtalem Global Education (ATGE) or Grand Canyon Education (LOPE) as potential undervalued stock options.
Why It Matters
The mention of Adtalem Global Education and Grand Canyon Education highlights potential investment opportunities in the undervalued schools sector, signaling possible growth or recovery.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About ATGE Stock
What is Adtalem Global Education Inc.'s (ATGE) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Adtalem Global Education Inc. (ATGE) has a median price target of $172.50. The highest price target is $175.00 and the lowest is $170.00.
Is ATGE stock a good investment in 2026?
According to current analyst ratings, ATGE has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $112.39. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ATGE stock?
Wall Street analysts predict ATGE stock could reach $172.50 in the next 12 months. This represents a 53.5% increase from the current price of $112.39. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Adtalem Global Education Inc.'s business model?
Covista Inc. generates revenue through its diverse educational offerings, including degree and non-degree programs across various fields such as nursing, health professions, and veterinary medicine. The company operates multiple universities and schools, allowing it to cater to a wide range of students and professionals seeking advanced education and certifications.
What is the highest forecasted price for ATGE Adtalem Global Education Inc.?
The highest price target for ATGE is $175.00 from at , which represents a 55.7% increase from the current price of $112.39.
What is the lowest forecasted price for ATGE Adtalem Global Education Inc.?
The lowest price target for ATGE is $170.00 from Alexander Paris at Barrington Research, which represents a 51.3% increase from the current price of $112.39.
What is the overall ATGE consensus from analysts for Adtalem Global Education Inc.?
The overall analyst consensus for ATGE is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $172.50.
How accurate are ATGE stock price projections?
Stock price projections, including those for Adtalem Global Education Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 1:28 AM UTC